Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
Jayaganesh V Natarajan1*, Marcus Ang2*, Anastasia Darwitan1, Sujay Chattopadhyay3, Tina T Wong2, Subbu S Venkatraman1 1Materials Science and Engineering, Nanyang Technological University, Singapore; 2Singapore Eye Research Institute, Singapore; 3Polymer Division, Indian Institute of Technology Roork...
Guardado en:
Autores principales: | Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2713e1fa08a1431d989499c9486fde02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Latanoprost in the treatment of glaucoma
por: Alm A
Publicado: (2014) -
Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella F, et al.
Publicado: (2012) -
Parents' views on their children's use of eye drops and willingness to accept a new sustained-release subconjunctival injection
por: Ozdemir S, et al.
Publicado: (2017) -
Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou MA, et al.
Publicado: (2018) -
Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
por: Kwon S, et al.
Publicado: (2020)